These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30181474)

  • 1. A Valine Mismatch at Position 129 of
    Michita RT; Chies JAB; Schramm S; Horn PA; Heinemann FM; Wunsch A; Viebahn R; Schenker P; Rebmann V
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.
    Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
    Front Immunol; 2018; 9():917. PubMed ID: 29867932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
    Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
    Front Immunol; 2018; 9():926. PubMed ID: 29765374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.
    Isernhagen A; Schilling D; Monecke S; Shah P; Elsner L; Walter L; Multhoff G; Dressel R
    Immunogenetics; 2016 Feb; 68(2):109-23. PubMed ID: 26585323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.
    Isernhagen A; Malzahn D; Viktorova E; Elsner L; Monecke S; von Bonin F; Kilisch M; Wermuth JM; Walther N; Balavarca Y; Stahl-Hennig C; Engelke M; Walter L; Bickeböller H; Kube D; Wulf G; Dressel R
    EMBO Mol Med; 2015 Nov; 7(11):1480-502. PubMed ID: 26483398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICA variant promotes allosensitization after kidney transplantation.
    Tonnerre P; Gérard N; Chatelais M; Poli C; Allard S; Cury S; Bressollette C; Cesbron-Gautier A; Charreau B
    J Am Soc Nephrol; 2013 May; 24(6):954-66. PubMed ID: 23539759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance.
    Hauer V; Risti M; Miranda BLM; da Silva JS; Cidral AL; Pozzi CM; Contieri FLC; Sadissou IA; Donadi EA; Augusto DG; Bicalho MDG
    PLoS One; 2019; 14(2):e0212750. PubMed ID: 30794652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation.
    Baranwal AK; Mehra NK
    Front Immunol; 2017; 8():182. PubMed ID: 28293239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks.
    Isernhagen A; Malzahn D; Bickeböller H; Dressel R
    Front Immunol; 2016; 7():588. PubMed ID: 28018354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MICA expression, anti-MICA antibodies and serum MICA during acute rejection in a rat-to-mouse cardiac transplantation model.
    Yu R; Xu S; Wang Y; Cai H; Xu P
    Int J Clin Exp Pathol; 2015; 8(11):14514-20. PubMed ID: 26823771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population.
    Douik H; Ben Chaaben A; Attia Romdhane N; Romdhane HB; Mamoghli T; Fortier C; Boukouaci W; Harzallah L; Ghanem A; Gritli S; Makni M; Charron D; Krishnamoorthy R; Guemira F; Tamouza R
    Hum Immunol; 2009 Jan; 70(1):45-8. PubMed ID: 19000729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population.
    Mariaselvam CM; Boukouaci W; Charron D; Krishnamoorthy R; Tamouza R; Misra DP; Negi VS
    Int J Rheum Dis; 2018 Mar; 21(3):656-663. PubMed ID: 28752674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection.
    Suárez-Alvarez B; López-Vázquez A; Díaz-Molina B; Bernardo-Rodríguez MJ; Alvarez-López R; Pascual D; Astudillo A; Martínez-Borra J; Lambert JL; González S; López-Larrea C
    Transplantation; 2006 Aug; 82(3):354-61. PubMed ID: 16906033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease.
    Boukouaci W; Al-Daccak R; Dulphy N; Lauden L; Amokrane K; Fortier C; Marzais F; Bennabi M; Peffault de Latour R; Socie G; Toubert A; Charron D; Krishnamoorthy R; Tamouza R
    Hum Immunol; 2013 Dec; 74(12):1536-41. PubMed ID: 23994587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation.
    Patel SS; Rybicki LA; Yurch M; Thomas D; Liu H; Dean R; Jagadeesh D; Hill B; Pohlman B; Bolwell B; Hanna R; Hamilton BK; Kalaycio M; Gerds AT; Cober E; Mossad S; Zhang A; Majhail NS; Askar M; Sobecks R
    Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):32-39. PubMed ID: 31881183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.
    Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P
    Front Immunol; 2021; 12():633658. PubMed ID: 34012432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study.
    Fechtenbaum M; Desoutter J; Delvallez G; Brochot E; Guillaume N; Goëb V
    Genes Immun; 2019 Sep; 20(7):599-605. PubMed ID: 30177859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk.
    Ouni N; Ben Chaaben A; Kablouti G; Lajnef M; Ayari F; Abaza H; Damak T; Harzallah L; Benammar-Elgaaeid A; Guemira F; Tamouza R
    Immunol Invest; 2017 Aug; 46(6):603-614. PubMed ID: 28742417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.